Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
To view or add a comment, sign in Eli Lilly blows past quarterly estimates, posts strong outlook as Zepbound and Mounjaro sales soar Eli Lilly's fourth-quarter earnings come as it tries to maintain its advantage over Novo Nordisk in the GLP-1 market
The short answer is indirectly
TB-500 (a Thymosin Beta-4 fragment) acts as a G-actin sequestering peptide affecting cytoskeletal remodelling and cell migration, with effects measured at the actin polymerization level rather than at receptor-pathway level
ReShape Lifesciences (RSLS) noted that GLP-1s have reduced initial consultations for its LAP-BAND Surgery. LastBearStanding on Substack Teleflex Incorporated, Q2 2023 Earnings Call, Aug 03, 2023: We continue to monitor the usage of GLP-1 drugs in treating obesity
US$ 24.61
US$ 21.16
US$ 26.37
US$ 28.02
US$ 28.65
US$ 26.01
US$ 23.41
